A recent study of “new generation” anti-depressants, like Prozac and Zoloft, concluded that they have little clinical effect on the majority of depressed patients. The conclusion suggests that since only the severely depressed really benefited from the drugs, their effect may be largely psychological and most people can get better without them.
The advent of the new-generation drugs in the late 80’s saw the rate of depression diagnoses increase 500 to 1000-fold. In 2005, the Centers for Disease Control and Prevention reported that 118 million of the 2.4 billion drugs prescribed in 2005 were antidepressants, making them the most commonly prescribed drugs in the US.
While some hail depression diagnosis and treatment as forward progress in combating a serious social-health issue, others argue that the increase in diagnoses is directly correlated to the effective marketing of pharmaceutical companies, and the doctors who are sitting pretty in their hip pockets.
There are doubtless people who suffer from crippling, life-threatening depression, and for them, medicine may be the best answer. But just because science enables us to understand what chemicals or genes cause depression, the solution does not lie perforce in drug remedies that dull the effects of those processes.
Clinical psychologist Michael Yapko has argued that the modern social and medical perspective on depression, as merely a brain disease, is too “one-dimensional.” “Striving to convince people they’re diseased doesn’t empower them to actively change their lives in meaningful ways,” wrote Yapko in a September 5, 2007 opinion piece in The Courier Mail. “We can teach better relationship skills, better problem-solving skills and better ways to cope with an increasingly complex world.”
The good news is that many people who think they are clinically depressed are, in fact, not. The question remains as to whether or not people are willing to undertake the work necessary to cope with their sadness instead of just popping “happy pills.” As one doctor put it, “we now have the expectation that we should never experience unhappiness.” If this is true, it might prove a boon for drug companies and doctors alike who profit from our institutionalized aversion to feeling sad.